Jump to content

Progressive supranuclear palsy: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
LeoO3 (talk | contribs)
mNo edit summary
Rationalised reference list. MJD. ~~~~
Line 13: Line 13:
MeshID = D013494 |
MeshID = D013494 |
}}
}}
'''Progressive supranuclear palsy''' ('''PSP''') (or the '''Steele-Richardson-Olszewski syndrome''', after the Canadian physicians who described it in 1963){{ref|1}}{{ref|2}} is a rare [[degenerative disease]] involving the gradual deterioration and death of selected areas of the [[brain]].
'''Progressive supranuclear palsy''' ('''PSP''') (or the '''Steele-Richardson-Olszewski syndrome''', after the Canadian physicians who described it in 1963)is a rare [[degenerative disease]] involving the gradual deterioration and death of selected areas of the [[brain]].
<ref> Richardson JC, Steele J, Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of "heterogeneous system degeneration". ''Trans Am Neurol Assoc'' 1963;88:25-9. PMID 14272249. </ref>
<ref> Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. ''Arch Neurol'' 1964;10:333-359. PMID 14107684. </ref>



The sexes are affected approximately equally and there is no racial, geographical or occupational predilection. Approximately 6 people per 100,000 population have PSP.
The sexes are affected approximately equally and there is no racial, geographical or occupational predilection. Approximately 6 people per 100,000 population have PSP.
Line 52: Line 55:


==Genetics==
==Genetics==
Fewer than 1% of those with PSP have a family member with the same disorder. A variant in the gene for tau protein called the H1 haplotype, located on chromosome 17, has been linked to PSP. Nearly all people with PSP received a copy of that variant from each parent, but this is true of about two-thirds of the general population. Therefore, the H1 haplotype appears to be necessary but not sufficient to cause PSP. Other genes, as well as environmental toxins are being investigated as other possible contributors to the cause of PSP.
Fewer than 1% of those with PSP have a family member with the same disorder. A variant in the gene for tau protein called the H1 haplotype, located on chromosome 17, has been linked to PSP.
<ref> {{OMIM|601104}} </ref>
Nearly all people with PSP received a copy of that variant from each parent, but this is true of about two-thirds of the general population. Therefore, the H1 haplotype appears to be necessary but not sufficient to cause PSP. Other genes, as well as environmental toxins are being investigated as other possible contributors to the cause of PSP.


==Notable cases==
==Notable cases==
Line 59: Line 64:
* American singer [[Teresa Brewer]] (''"[[Music! Music! Music!]]"''), 76, died of this disease on [[October 17]], [[2007]].
* American singer [[Teresa Brewer]] (''"[[Music! Music! Music!]]"''), 76, died of this disease on [[October 17]], [[2007]].
* [[Film Director]] and [[Playwright]] [[Joshua Logan]]
* [[Film Director]] and [[Playwright]] [[Joshua Logan]]
* Dr Anne Turner, who was the basis of the BBC drama [http://www.imdb.com/title/tt1273813''A Short Stay in Switzerland''] about assisted suicide.<ref>{{cite web|url=http://www.dignityindying.org.uk/personal-stories/uk/south-west/bath/dr-anne-turner-story-9.html|title=Dr Anne Turner|work=Dignity in Dying|accessdate=2009-01-25}}</ref>
* Dr Anne Turner, who was the basis of the BBC drama [http://www.imdb.com/title/tt1273813''A Short Stay in Switzerland''] about assisted suicide. <ref>{{cite web|url=http://www.dignityindying.org.uk/personal-stories/uk/south-west/bath/dr-anne-turner-story-9.html|title=Dr Anne Turner|work=Dignity in Dying|accessdate=2009-01-25}}</ref>


==Support groups==
==Support groups==
Line 65: Line 70:


==References==
==References==
# {{note|1}} Richardson JC, Steele J, Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of "heterogeneous system degeneration". ''Trans Am Neurol Assoc'' 1963;88:25-9. PMID 14272249.
# {{note|2}} Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. ''Arch Neurol'' 1964;10:333-359. PMID 14107684.
# {{note|3}} {{OMIM|601104}}
{{reflist}}
{{reflist}}



Revision as of 16:12, 8 May 2009

Progressive supranuclear palsy
SpecialtyNeurology Edit this on Wikidata

Progressive supranuclear palsy (PSP) (or the Steele-Richardson-Olszewski syndrome, after the Canadian physicians who described it in 1963)is a rare degenerative disease involving the gradual deterioration and death of selected areas of the brain. [1] [2]


The sexes are affected approximately equally and there is no racial, geographical or occupational predilection. Approximately 6 people per 100,000 population have PSP.

Symptoms and signs

The initial symptom in two-thirds of cases is loss of balance and falls. Other common early symptoms are changes in personality, general slowing of movement, and visual symptoms.

Later symptoms and signs are dementia (typically including loss of inhibition and ability to organize information), slurring of speech, difficulty swallowing, and difficulty moving the eyes, particularly in the vertical direction. The latter accounts for some of the falls experienced by these patients as they are unable to look up or down.

Some of the other signs are poor eyelid function, contracture of the facial muscles, a backward tilt of the head with stiffening of the neck muscles, sleep disruption, urinary incontinence and constipation.

The visual symptoms are of particular importance in the diagnosis of this disorder. Notably, the ophthalmoplegia experienced by these patients mainly concerns voluntary eye movement. Involuntary eye movement, as elicited by Bell's phenomenon, for instance, may be closer to normal. On close inspection, eye movements called "square wave jerks" may be visible when the patient fixes at distance. These are fine movements, similar to nystagmus, except that they are not rhythmic in nature. Difficulties with convergence, where the eyes come closer together while focusing on something near, like the pages of a book, is typical. Because the eyes have trouble coming together to focus on things at near, the patient may complain of double vision when reading.

Cardinal Manifestations:

  • Supranuclear ophthalmoplegia
  • Neck dystonia
  • Parkinsonism
  • Pseudobulbar palsy
  • Behavioral and Cognitive impairment
  • Imbalance and Difficulties walking
  • Frequent Falls

Prognosis

There is currently no effective treatment or cure for PSP, although some of the symptoms can respond to nonspecific measures. The average age at symptoms onset is 63 and survival from that point averages 7 years with a wide variance.

Differential diagnosis

PSP is frequently misdiagnosed as Parkinson's disease because of the slowed movements and gait difficulty, or as Alzheimer's Disease because of the behavioral changes. It is one of a number of diseases collectively referred to as Parkinson plus syndromes.

Pathophysiology

The affected brain cells are both neurons and glial cells. The neurons display neurofibrillary tangles, which are clumps of tau protein, a normal part of a brain cell's internal structural skeleton.

The principal areas of the brain affected are:

Genetics

Fewer than 1% of those with PSP have a family member with the same disorder. A variant in the gene for tau protein called the H1 haplotype, located on chromosome 17, has been linked to PSP. [3] Nearly all people with PSP received a copy of that variant from each parent, but this is true of about two-thirds of the general population. Therefore, the H1 haplotype appears to be necessary but not sufficient to cause PSP. Other genes, as well as environmental toxins are being investigated as other possible contributors to the cause of PSP.

Notable cases

Support groups

Several international organizations serve the needs of patients with PSP and their families and support research. The Society for PSP ("CurePSP") is based in the US and the PSP Association (PSP-Europe Association) is based in the UK.

References

  1. ^ Richardson JC, Steele J, Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of "heterogeneous system degeneration". Trans Am Neurol Assoc 1963;88:25-9. PMID 14272249.
  2. ^ Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359. PMID 14107684.
  3. ^ Online Mendelian Inheritance in Man (OMIM): 601104
  4. ^ "Dr Anne Turner". Dignity in Dying. Retrieved 2009-01-25.

External links